Results
Sudeep Pharma FY26 Net Profit ₹174.3 Cr, Declares ₹1.50 Dividend
• Board approved audited standalone and consolidated financial results for Q4 and FY ended 31 March 2026, with consolidated net profit of ₹174.28 crore.
• Recommended a final dividend of ₹1.50 (150%)